Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SynergyRx outlines how its telehealth platform connects patients with licensed providers for GLP-1 evaluation, pricing context, and pathways.
-
Analysis examines Direct Meds GLP-1 medications platform as LegitScript-certified telehealth option for compounded semaglutide and tirzepatide access.
-
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable and needle-free formats.
-
JAIPUR, India, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Almas Jiwani, President Emeritus of UN Women Canada and CEO of the Almas Jiwani Foundation, will address the TiE Global Summit, one of the world’s...
-
New York City, NY, Dec. 26, 2025 (GLOBE NEWSWIRE) -- In a world where chronic stress, anxiety, poor sleep, and mental fatigue have become the norm rather than the exception, Pulsetto is...
-
New York City, NY, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Introduction Wolfson Brands has unveiled an advanced line of fat-burning supplements that aim to reshape how men approach weight management,...
-
Beijing, China, Dec. 26, 2025 (GLOBE NEWSWIRE) -- In a large private hospital in Al-Ahsa, Saudi Arabia, Chinese-made service robots have been introduced to handle routine delivery tasks — such as...
-
RankOS™ analysis finds below 18% of financial services and insurance brands appear in AI search, underscoring the role of authority and trust signals.
-
FDA approves oral Wegovy pill Dec 2025. Analysis compares FDA-approved injectable, oral, and compounded semaglutide access pathways for 2026.
-
Green Goo highlights growing interest in science-informed, plant-based alternatives to conventional first-aid ointments.